PRaG5.0 combined with chemotherapy and sequential chemoimmunotherapy for massive SMARCA4-deficient undifferentiated tumor of the cervix: case report - Scorecard - MDSpire

PRaG5.0 combined with chemotherapy and sequential chemoimmunotherapy for massive SMARCA4-deficient undifferentiated tumor of the cervix: case report

  • By

  • Zixin Li

  • Xuezhou Pang

  • Zhongyao Wang

  • Jing Wen

  • Yanli Zhao

  • Daiyuan Ma

  • Jianquan Yang

  • May 8, 2026

  • 0 min

Share

Clinical Scorecard: Case Report: Management of a Large SMARCA4-Deficient Undifferentiated Cervical Tumor Using PRaG5.0 in Combination with Chemotherapy and Sequential Chemoimmunotherapy

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients with large, resistant cervical tumors (≥ 4 cm), particularly those with advanced disease.
Care Setting

Key Highlights

  • timeline

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • S
      • p
      • e
      • c
      • i
      • f
      • y
      • i
      • m
      • a
      • g
      • i
      • n
      • g
      • m
      • o
      • d
      • a
      • l
      • i
      • t
      • i
      • e
      • s
      • s
      • u
      • c
      • h
      • a
      • s
      • C
      • T
      • o
      • r
      • M
      • R
      • I
      • f
      • o
      • r
      • r
      • e
      • g
      • u
      • l
      • a
      • r
      • a
      • s
      • s
      • e
      • s
      • s
      • m
      • e
      • n
      • t
      • s
      • .

      Risks

        Patient & Prescribing Data

        Clinical Best Practices

        • renal_monitoring

        Related Resources & Content

          Original Source(s)

          PRaG5.0 combined with chemotherapy and sequential chemoimmunotherapy for massive SMARCA4-deficient undifferentiated tumor of the cervix: case report

          • by Zixin Li, Xuezhou Pang, Zhongyao Wang, Jing Wen, Yanli Zhao, Daiyuan Ma, Jianquan Yang

          • May 8, 2026

          Related Content

          Lymph Node Dissection and Postoperative Complications After Lung Cancer Resection

          Clinical heterogeneity and treatment optimization in anti-KLHL11 encephalitis: two case reports and literature review

          Application of patient-derived organotypic tumor spheroids to guide combination immunotherapy for advanced HCC: a case report